Addressing Financial Toxicity With Navigators and Better Conversations Around Decision Making

Financial toxicity impacts a lot more than a patient's finances—it leads to nonadherence and poorer health outcomes. Financial navigators are increasingly being used to be proactive about addressing high healthcare costs and the resulting financial toxicity.

Health literacy in the United States is low to begin with, and health financial literacy is even lower. The changing health insurance system is partly to blame. A few decades ago, health insurance covered everything. Now, patients have a lot more financial responsibility, and they don’t always understand it. In cancer, health financial literacy is particularly important since treatment can be so costly.

This episode of Managed Care Cast includes conversations with a few experts in the field: Yousuf Zafar, MD, MHS, of the Duke Cancer Institute; Clara Lambert, BBA, OPN-CG, chair of the Association of Community Cancer Centers Financial Advocacy Network Advisory Committee; Todd Yezefski, MD, senior fellow in the Clinical Research Division at the Fred Hutchinson Cancer Research Center and Division of Medical Oncology at the University of Washington; and Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation.

To listen, login to the website.




Listen above or through one of these podcast services:

A Descriptive Study of Patients Receiving Foundational Financial Assistance Through Local Specialty Pharmacies:

Impact of Trained Oncology Financial Navigators on Patient Out-of-Pocket Spending:

Policy Improvement Areas to Reduce Financial Hardship:

Addressing Financial Concerns at the Outset to Improve Patient Outcomes:

Read more:

Related Videos
Samyukta Mullangi, MD, MBA.
Manmeet Ahluwalia, MD, MBA.
Jeff Hunnicutt, CEO, Highlands Oncology Group
Sigrun Hallmeyer, MD, Advocate Health
Kevin Davies, PhD, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing
Andre Harvin, PharmD, MS, MBA, Cone Health Cancer Center
Samyukta Mullangi, MD, MBA.
Olalekan Ajayi, PharmD, MBA, 2023-2024 ACCC president-elect
Sashi Naidu, MD, Carolina Blood and Cancer Care Associates
Stephen M. Schleicher, MD, MBA, Tennessee Oncology
Related Content
© 2023 MJH Life Sciences
All rights reserved.